Rare Diseases in Europe: the Portuguese framework
نویسندگان
چکیده
منابع مشابه
A methodological framework for drug development in rare diseases
INTRODUCTION Developing orphan drugs is challenging because of their severity and the requisite for effective drugs. The small number of patients does not allow conducting adequately powered randomized controlled trials (RCTs). There is a need to develop high quality, ethically investigated, and appropriately authorized medicines, without subjecting patients to unnecessary trials. AIMS AND OB...
متن کاملThe present situation of Rare Diseases in Central/Eastern Europe? The role of patient organisations
Results 1, At the level of medical and social services: It is still “incidental” to get to the appropriate expert or centre for diagnosis or treatment. It is difficult to find even the services, because of the lack of suitable “pathways” and referral. There are long delays in obtaining the first appointment, resulting in defencelessness and regional irregularity. The overall consequence is the ...
متن کاملRare diseases research in Europe: an overview based on data from the Orphanet database
Orphanet compiles 6500 research projects. This information been analysed to identify areas in need of collaborative research projects and to target future calls for proposals. The analysis of the distribution of number of diseases by number of treatments in development showed that most RD have no more than 3 orphan designations, whereas 53 RD have over three orphan designations. Similar results...
متن کاملNational registries of rare diseases in Europe: an overview of the current situation and experiences.
The European Union (EU) policy for healthcare requires the establishment of a system of European Reference Networks, union-wide information databases, and registries for rare diseases (RDs) based on shared criteria. In pursuing its goals, the 'Building Consensus and Synergies for the EU Registration of RD Patients in Europe' (EPIRARE) project convened a meeting with experts of the competent hea...
متن کاملPerspectives for improving the evaluation and access of therapies for rare lung diseases in Europe.
The approach to treating a rare disease is different to that taken for more common diseases. Small patient cohorts alter clinical trial design and limit enrollment, and the picture for rare lung diseases is further complicated by the fact that most are composed of a variety of clinical phenotypes. Since the outcome measures of lung impairment have considerable test-to-test variability, potentia...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Public Health
سال: 2015
ISSN: 1464-360X,1101-1262
DOI: 10.1093/eurpub/ckv175.169